Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET)

Standard

Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET). / Nabauer, Michael; Oeff, Michael; Gerth, Andrea; Wegscheider, Karl; Buchholz, Anika; Haeusler, Karl Georg; Hanrath, Peter; Meinertz, Thomas; Ravens, Ursula; Sprenger, Claudia; Tebbe, Ulrich; Vettorazzi, Eik; Kirchhof, Paulus; Breithardt, Günter; Steinbeck, Gerhard; AFNET registry investigators.

In: EUROPACE, Vol. 23, No. 12, 07.12.2021, p. 1903-1912.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Nabauer, M, Oeff, M, Gerth, A, Wegscheider, K, Buchholz, A, Haeusler, KG, Hanrath, P, Meinertz, T, Ravens, U, Sprenger, C, Tebbe, U, Vettorazzi, E, Kirchhof, P, Breithardt, G, Steinbeck, G & AFNET registry investigators 2021, 'Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET)', EUROPACE, vol. 23, no. 12, pp. 1903-1912. https://doi.org/10.1093/europace/euab113

APA

Nabauer, M., Oeff, M., Gerth, A., Wegscheider, K., Buchholz, A., Haeusler, K. G., Hanrath, P., Meinertz, T., Ravens, U., Sprenger, C., Tebbe, U., Vettorazzi, E., Kirchhof, P., Breithardt, G., Steinbeck, G., & AFNET registry investigators (2021). Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET). EUROPACE, 23(12), 1903-1912. https://doi.org/10.1093/europace/euab113

Vancouver

Bibtex

@article{2ce705321cbe4cd5a2383ddbc7141e85,
title = "Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET)",
abstract = "AIMS: Atrial fibrillation (AF) is associated with a high risk of cardiovascular and non-cardiovascular death, even on anticoagulation. It is controversial, which conditions-including concomitant diseases and AF itself-contribute to this mortality. To further clarify these questions, major determinants of long-term mortality and their contribution to death were quantified in an unselected cohort of AF patients.METHODS AND RESULTS: We established a large nationwide registry comprising 8833 AF-patients with a median follow-up of 6.5 years (45 345 patient-years) and central adjudication of adverse events. Baseline characteristics of the patients were evaluated as predictors of mortality using Cox regression and C-indices for determination of predictive power. Annualized mortality was highest in the first year (6.2%) and remained high thereafter (5.2% in men and 5.5% in women). Thirty-eight percent of all deaths were cardiovascular, mainly due to heart failure or sudden death. Sex-specific age was the strongest predictor of mortality, followed by concomitant cardiovascular and non-cardiovascular conditions. These factors accounted for 25% of the total mortality beyond age and sex and for 84% of the mortality differences between AF types. Thus, the electrical phenotype of the disease at baseline contributed only marginally to prediction of mortality.CONCLUSION: Mortality is high in AF patients and arises primarily from heart failure, peripheral artery disease, chronic obstructive lung disease, chronic kidney disease, and diabetes mellitus, which, therefore, should be targeted to lower mortality. Parameters related to the electrical manifestation of AF did not have an independent impact on long-term mortality in our representative cohort.",
author = "Michael Nabauer and Michael Oeff and Andrea Gerth and Karl Wegscheider and Anika Buchholz and Haeusler, {Karl Georg} and Peter Hanrath and Thomas Meinertz and Ursula Ravens and Claudia Sprenger and Ulrich Tebbe and Eik Vettorazzi and Paulus Kirchhof and G{\"u}nter Breithardt and Gerhard Steinbeck and {AFNET registry investigators}",
note = "Published on behalf of the European Society of Cardiology. All rights reserved. {\textcopyright} The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.",
year = "2021",
month = dec,
day = "7",
doi = "10.1093/europace/euab113",
language = "English",
volume = "23",
pages = "1903--1912",
journal = "EUROPACE",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "12",

}

RIS

TY - JOUR

T1 - Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET)

AU - Nabauer, Michael

AU - Oeff, Michael

AU - Gerth, Andrea

AU - Wegscheider, Karl

AU - Buchholz, Anika

AU - Haeusler, Karl Georg

AU - Hanrath, Peter

AU - Meinertz, Thomas

AU - Ravens, Ursula

AU - Sprenger, Claudia

AU - Tebbe, Ulrich

AU - Vettorazzi, Eik

AU - Kirchhof, Paulus

AU - Breithardt, Günter

AU - Steinbeck, Gerhard

AU - AFNET registry investigators

N1 - Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

PY - 2021/12/7

Y1 - 2021/12/7

N2 - AIMS: Atrial fibrillation (AF) is associated with a high risk of cardiovascular and non-cardiovascular death, even on anticoagulation. It is controversial, which conditions-including concomitant diseases and AF itself-contribute to this mortality. To further clarify these questions, major determinants of long-term mortality and their contribution to death were quantified in an unselected cohort of AF patients.METHODS AND RESULTS: We established a large nationwide registry comprising 8833 AF-patients with a median follow-up of 6.5 years (45 345 patient-years) and central adjudication of adverse events. Baseline characteristics of the patients were evaluated as predictors of mortality using Cox regression and C-indices for determination of predictive power. Annualized mortality was highest in the first year (6.2%) and remained high thereafter (5.2% in men and 5.5% in women). Thirty-eight percent of all deaths were cardiovascular, mainly due to heart failure or sudden death. Sex-specific age was the strongest predictor of mortality, followed by concomitant cardiovascular and non-cardiovascular conditions. These factors accounted for 25% of the total mortality beyond age and sex and for 84% of the mortality differences between AF types. Thus, the electrical phenotype of the disease at baseline contributed only marginally to prediction of mortality.CONCLUSION: Mortality is high in AF patients and arises primarily from heart failure, peripheral artery disease, chronic obstructive lung disease, chronic kidney disease, and diabetes mellitus, which, therefore, should be targeted to lower mortality. Parameters related to the electrical manifestation of AF did not have an independent impact on long-term mortality in our representative cohort.

AB - AIMS: Atrial fibrillation (AF) is associated with a high risk of cardiovascular and non-cardiovascular death, even on anticoagulation. It is controversial, which conditions-including concomitant diseases and AF itself-contribute to this mortality. To further clarify these questions, major determinants of long-term mortality and their contribution to death were quantified in an unselected cohort of AF patients.METHODS AND RESULTS: We established a large nationwide registry comprising 8833 AF-patients with a median follow-up of 6.5 years (45 345 patient-years) and central adjudication of adverse events. Baseline characteristics of the patients were evaluated as predictors of mortality using Cox regression and C-indices for determination of predictive power. Annualized mortality was highest in the first year (6.2%) and remained high thereafter (5.2% in men and 5.5% in women). Thirty-eight percent of all deaths were cardiovascular, mainly due to heart failure or sudden death. Sex-specific age was the strongest predictor of mortality, followed by concomitant cardiovascular and non-cardiovascular conditions. These factors accounted for 25% of the total mortality beyond age and sex and for 84% of the mortality differences between AF types. Thus, the electrical phenotype of the disease at baseline contributed only marginally to prediction of mortality.CONCLUSION: Mortality is high in AF patients and arises primarily from heart failure, peripheral artery disease, chronic obstructive lung disease, chronic kidney disease, and diabetes mellitus, which, therefore, should be targeted to lower mortality. Parameters related to the electrical manifestation of AF did not have an independent impact on long-term mortality in our representative cohort.

U2 - 10.1093/europace/euab113

DO - 10.1093/europace/euab113

M3 - SCORING: Journal article

C2 - 34136917

VL - 23

SP - 1903

EP - 1912

JO - EUROPACE

JF - EUROPACE

SN - 1099-5129

IS - 12

ER -